Sleep maintenance insomnia is the most common form of sleep disturbance encountered and carries the greatest personal and societal burden, especially in older adults. Despite this, there is a huge unmet need associated with managing sleep maintenance insomnia, as shorter-acting agents are ineffective in maintaining sleep and longer-acting agents, especially those that act on the gamma-aminobutyric acid (GABA) receptor, result in next-day residual and hangover effects, which place older adults at risk for falls. Recently, new agents have begun to emerge that act on orexin receptors and have been demonstrated to have fewer residual effects. Clinicians need to be aware of these, and their distinct mechanism of action, so that sleep maintenance insomnia sufferers are more optimally treated with fewer risks of side effects. In this activity, you will learn about the impact and management of sleep maintenance insomnia, including current approaches, as well as novel and emerging treatments.
Upon completion of this activity, participants should be better able to:
Founder and Director
Atlanta School of Sleep Medicine and Technology
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources